Procarta Biosystems Ltd.

4 employees

Procarta Biosystems develops antibacterials through an adaptable DNA-based platform to counter the rise of drug-resistant bacterial strains.

Basic info

biotechnology

Biotechnology

Health Care

Therapeutics

Pharmaceutical

2007

$9.2M

from 16 investors over 16 rounds

Procarta Biosystems Ltd. raised $9.2M on September 17, 2019

Investors: CARB-X

Procarta Biosystems Ltd. raised $1.7M on March 5, 2019

Investors: REPAIR Impact Fund, UK Innovation & Science Seed Fund, Meltwind Advisory LLP, Development Bank of Wales and Wren Capital LLP

Procarta Biosystems Ltd. raised undisclosed on April 23, 2018

Investors: Future Planet Capital and UK Innovation & Science Seed Fund

Procarta Biosystems Ltd. raised undisclosed on July 1, 2016

Investors: Future Planet Capital

Procarta Biosystems Ltd. raised $1.2M on November 10, 2010

Investors: Iceni Seedcorn Fund and UK Innovation & Science Seed Fund

Procarta Biosystems Ltd. raised $631K on June 6, 2008

Investors: Midven and Future Planet Capital

Procarta Biosystems Ltd. raised $641K on July 1, 2007

Investors: UK Innovation & Science Seed Fund, Future Planet Capital and Iceni Seedcorn Fund